Axcella Health Inc.
COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES AND THALASSEMIAS

Last updated:

Abstract:

This disclosure provides compositions and methods for improving erythrocyte dysfunction or treating a hemoglobinopathy or a thalassemia (e.g., sickle cell disease or .beta.-thalassemia).

Status:
Application
Type:

Utility

Filling date:

8 Jun 2021

Issue date:

23 Sep 2021